Infectious Diseases (except HIV/AIDS)

  1. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition

    1. Thandeka Nkosi
    2. Caroline Chasara
    3. Andrea O Papadopoulos
    4. Tiza L Nguni
    5. Farina Karim
    6. Mahomed-Yunus S Moosa
    7. Inbal Gazy
    8. Kondwani Jambo
    9. COMMIT-KZN-Team
    10. Willem Hanekom
    11. Alex Sigal
    12. Zaza M Ndhlovu

    • Curated by eLife

      Evaluation Summary:

      The study shows that individuals with unsuppressed HIV infection had poorer T cell polyfunctionality and lower cross-reactive responses to SARS-CoV-2 variants compared to those who were HIV negative or aviremic. The conclusions of this paper are well supported by the data and will be of interest to clinicians, immunologists, and public health practitioners, particularly in Southern Africa.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife, ScreenIT

    6 evaluationsAppears in 2 listsLatest version Latest activity

  2. Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area

    1. Wendy K. Tam Cho
    2. David G. Hwang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

    1. Sammy Huygens
    2. Bas Oude Munnink
    3. Arvind Gharbharan
    4. Marion Koopmans
    5. Bart Rijnders

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. From Alpha to Omicron BA.2: New digital RT-PCR approach and challenges for SARS-CoV-2 VOC monitoring and normalization of variant dynamics in wastewater

    1. Sebastien Wurtzer
    2. Morgane Levert
    3. Eloïse Dhenain
    4. Heberte Accrombessi
    5. Sandra Manco
    6. Nathalie Fagour
    7. Marion Goulet
    8. Nicolas Boudaud
    9. Lucie Gaillard
    10. Isabelle Bertrand
    11. Julie Challant
    12. Sophie Masnada
    13. Sam Azimi
    14. Miguel Gillon-Ritz
    15. Alban Robin
    16. Jean-Marie Mouchel
    17. Obepine Sig
    18. Laurent Moulin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Effect of heat inactivation and bulk lysis on real-time reverse transcription PCR detection of the SARS-COV-2: an experimental study

    1. Dereje Leta
    2. Gadissa Gutema
    3. Gebremedhin Gebremichael Hagos
    4. Regasa Diriba
    5. Gutema Bulti
    6. Tolawak Sura
    7. Desta Ayana
    8. Dawit Chala
    9. Boki Lenjiso
    10. Jaleta Bulti
    11. Saro Abdella
    12. Habteyes Hailu Tola

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022

    1. Yosuke Hirotsu
    2. Makoto Maejima
    3. Masahiro Shibusawa
    4. Yume Natori
    5. Yuki Nagakubo
    6. Kazuhiro Hosaka
    7. Hitomi Sueki
    8. Hitoshi Mochizuki
    9. Toshiharu Tsutsui
    10. Yumiko Kakizaki
    11. Yoshihiro Miyashita
    12. Masao Omata

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study

    1. Maria Elena Romero-Ibarguengoitia
    2. Arnulfo González-Cantú
    3. Diego Rivera-Salinas
    4. Yodira Guadalupe Hernández-Ruíz
    5. Ana Gabriela Armendariz-Vázquez
    6. Irene Antonieta Barco-Flores
    7. Rosalinda González-Facio
    8. Miguel Ángel Sanz-Sánchez

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach

    1. Erin C. Williams
    2. Alexander Kizhner
    3. Valerie S. Stark
    4. Aria Nawab
    5. Daniel D. Muniz
    6. Felipe Echeverri Tribin
    7. Juan Manuel Carreño
    8. Dominika Bielak
    9. Gagandeep Singh
    10. Michael E. Hoffer
    11. Florian Krammer
    12. Suresh Pallikkuth
    13. Savita Pahwa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

    1. Midori Johnston
    2. H. Ceren Ates
    3. Regina T. Glatz
    4. Hasti Mohsenin
    5. Rosanne Schmachtenberg
    6. Nathalie Göppert
    7. Daniela Huzly
    8. Gerald A. Urban
    9. Wilfried Weber
    10. Can Dincer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data

    1. Yosuke Hirotsu
    2. Makoto Maejima
    3. Masahiro Shibusawa
    4. Yume Natori
    5. Yuki Nagakubo
    6. Kazuhiro Hosaka
    7. Hitomi Sueki
    8. Hitoshi Mochizuki
    9. Toshiharu Tsutsui
    10. Yumiko Kakizaki
    11. Yoshihiro Miyashita
    12. Masao Omata

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 175 of 716 Next